- MedeAnalytics is a healthcare performance improvement company based in Richardson, Texas, specializing in AI-driven, cloud-native solutions that enhance performance for payers, providers, and employers by reducing costs and improving medical loss ratios (MLR).
- In the past year, MedeAnalytics appointed Chris Lance as Chief Product Officer and David Figueredo as Chief Innovation Officer, and announced a strategic partnership with Basys.ai to enhance healthcare utilization management on December 8, 2025.
- The company serves over thirty years as a healthcare intelligence partner, showcasing its solutions at key industry events like HIMSS 2026 and Becker's Payer Issues, emphasizing its commitment to transforming healthcare analytics.
- MedeAnalytics targets health plans and employers seeking to improve financial performance and care outcomes, addressing the need for actionable insights over traditional analytics, making it a timely opportunity for sales engagement.
MedeAnalytics employs a diverse workforce across 14 departments, with the Information Technology department being the largest, comprising 87 employees. Operations and Executive departments follow, with 41 and 22 employees respectively. This distribution indicates a strong emphasis on IT and operational efficiency, while also maintaining a balanced representation in executive leadership, sales, and engineering functions.
The company operates in 44 locations, with the largest concentration in Richardson, TX, housing 63 employees. Other notable locations include Dublin, CA, with 9 employees, and several sites in Texas such as Dallas and Nashville, each contributing 3 employees. The significant headcount in 'Other' locations, totaling 146, suggests a distributed workforce model, highlighting MedeAnalytics' reach across various regions.
